🔗 Permalink

Inventor profile of:

Bin Wang

City:

Longmont, Colorado

Country:

United States

Published Applications:

Last publication date:

2012-08-16

Top Assignees for applications by Bin Wang

The entities that hold a legal rights for patent applications filed by inventor Wang Bin:

AstraZeneca AB 6 Sodertalje, Sweden
INTERMUNE ,INC. 5 Brisbane, CA United States
ARRAY BIOPHARMA INC. 4 Boulder, CO United States
ASTRAZENECA R&D 2 Sodertalje, Sweden
AstraZeneca 1 Sodertalje, Sweden
ASTRAZENECA AB 1 , Sweden
ASTRAZENECA AB 1 Sodrtalje, Sweden

Recent patent applications by Wang Bin

Bin Wang from Longmont, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2012-08-16

US20120208995A1

Chemistry; metallurgy

Macrocyclic inhibitors of hepatitis C virus replication

#2 | 2012-03-22

US20120071480A1

Chemistry; metallurgy

4-(3-AMINOPYRAZOLE) PYRIMIDINE DERIVATIVES FOR USE AS TYROSINE KINASE INHIBITORS IN THE TREATMENT OF CANCER

#3 | 2010-08-19

US20100210648A1

Chemistry; metallurgy

Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors

#4 | 2010-06-24

US20100160325A1

Chemistry; metallurgy

4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer

#5 | 2009-12-03

US20090297476A1

Chemistry; metallurgy

Peptide inhibitors of hepatitis C virus replication

#6 | 2009-09-10

US20090227648A1

Chemistry; metallurgy

PYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF CANCER

#7 | 2009-07-02

US20090169510A1

Chemistry; metallurgy

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#8 | 2009-06-18

US20090155209A1

Chemistry; metallurgy

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#9 | 2009-06-11

US20090148407A1

Chemistry; metallurgy

Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication

#10 | 2009-05-28

US20090137624A1

Chemistry; metallurgy

Chemical compounds

#11 | 2008-11-20

US20080287475A1

Chemistry; metallurgy

4-(3-Aminopyrazole) Pyrimidine Derivatives for Use as Tyrosine Kinase Inhibitors in the Treatment of Cancer

#12 | 2008-11-20

US20080287437A1

Chemistry; metallurgy

Pyrazolylaminopyrimidine Derivatives Useful as Tyrosine Kinase Inhibitors

#13 | 2008-07-24

US20080176872A1

Chemistry; metallurgy

Chemical compounds

#14 | 2008-06-12

US20080139561A1

Chemistry; metallurgy

Pyrazolylaminopyridine derivatives useful as kinase inhibitors

#15 | 2007-03-08

US20070054842A1

Chemistry; metallurgy

Macrocyclic inhibitors of hepatitis C virus replication

#16 | 2005-06-16

US20050130954A1

Chemistry; metallurgy

AKT protein kinase inhibitors

InventorID:

3127051 ⎘